Patent details

EP1355910 Title: FORMULATION OF BORONIC ACID COMPOUNDS

Basic Information

Publication number:
EP1355910
PCT Application Number:
PCT/US/2002/001907
Type:
European Patent Granted for LU
Legal Status:
Revoked
Application number:
EP027091453
PCT Publication Number:
WO/2002/059130
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
FORMULATION OF BORONIC ACID COMPOUNDS
French Title of Invention:
FORMULATION DE COMPOSES D'ACIDE BORONIQUE
German Title of Invention:
FORMULIERUNGEN VON BORSÄURE-VERBINDUNGEN
SPC Number:

Dates

Filing date:
25/01/2002
Grant date:
09/03/2011
EP Publication Date:
09/03/2011
PCT Publication Date:
01/08/2002
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
29/10/2003
EP B1 Publication Date:
09/03/2011
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
25/01/2022
Renunciation date:
Revocation date:
29/09/2016
Annulment date:

Owner

From:
25/01/2002
 
 

Name:
The United States of America represented by the
Address:
National Institutes of Health, Office of Technology Transfe, Rockville, MD 20852, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
09/03/2011
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

Name:
GUPTA Shanker
Address:
United States (US)

Priority

Priority Number:
264160 P
Priority Date:
25/01/2001
Priority Country:
United States (US)

Classification

Main IPC Class:
C07F 5/02;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
26/01/2016
Last Annual Fee Paid Number:
15
Last Annual Fee Paid Amount:
213 Euro
Payer:
OFFICE FREYLINGER S.A.
Filing date Document type Number of pages